DK85490A - Krystallinsk (5r,6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penemcarboxylsyre og dens farmaceutiske formulering - Google Patents

Krystallinsk (5r,6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penemcarboxylsyre og dens farmaceutiske formulering Download PDF

Info

Publication number
DK85490A
DK85490A DK085490A DK85490A DK85490A DK 85490 A DK85490 A DK 85490A DK 085490 A DK085490 A DK 085490A DK 85490 A DK85490 A DK 85490A DK 85490 A DK85490 A DK 85490A
Authority
DK
Denmark
Prior art keywords
carbamoyloxymethyl
hydroxyethyl
crystallic
pharmaceutical formulation
acid
Prior art date
Application number
DK085490A
Other languages
English (en)
Other versions
DK171235B1 (da
DK85490D0 (da
Inventor
Carlo Battistini
Roberto Bianchini
Stefano Del Nero
Pierluigi Griggi
Sergio Vioglio
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of DK85490D0 publication Critical patent/DK85490D0/da
Publication of DK85490A publication Critical patent/DK85490A/da
Application granted granted Critical
Publication of DK171235B1 publication Critical patent/DK171235B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/86—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with only atoms other than nitrogen atoms directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK085490A 1988-08-08 1990-04-05 Krystallinsk (5R,6S)-2-carbamoyloxymethyl-6-[(IR)-hydroxyethyl]-2-penemcarboxylsyre, fremgangsmåde til fremstilling heraf, samt farmaceutisk præparat indeholdende syren DK171235B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888818789A GB8818789D0 (en) 1988-08-08 1988-08-08 Crystalline(5r 6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penem-carboxylic acid & pharmaceutical formulation
GB8818789 1988-08-08
PCT/EP1989/000924 WO1990001484A1 (en) 1988-08-08 1989-08-04 Crystalline (5r,6s)-2-carbamoyloxymethyl-6-[(1r)-hydroxyethyl]-2-penem-carboxylic acid and its pharmaceutical formulation
EP8900924 1989-08-04

Publications (3)

Publication Number Publication Date
DK85490D0 DK85490D0 (da) 1990-04-05
DK85490A true DK85490A (da) 1990-06-07
DK171235B1 DK171235B1 (da) 1996-08-05

Family

ID=10641768

Family Applications (1)

Application Number Title Priority Date Filing Date
DK085490A DK171235B1 (da) 1988-08-08 1990-04-05 Krystallinsk (5R,6S)-2-carbamoyloxymethyl-6-[(IR)-hydroxyethyl]-2-penemcarboxylsyre, fremgangsmåde til fremstilling heraf, samt farmaceutisk præparat indeholdende syren

Country Status (21)

Country Link
US (1) US5302588A (da)
EP (1) EP0407478B1 (da)
JP (1) JP2954956B2 (da)
KR (1) KR900701799A (da)
AT (1) ATE112777T1 (da)
AU (1) AU626576B2 (da)
CA (1) CA1339422C (da)
DE (1) DE68918849T2 (da)
DK (1) DK171235B1 (da)
ES (1) ES2015770A6 (da)
FI (1) FI95575C (da)
GB (1) GB8818789D0 (da)
GR (1) GR1002251B (da)
HU (1) HU205934B (da)
IE (1) IE68447B1 (da)
IL (1) IL91216A (da)
NZ (1) NZ230196A (da)
PT (1) PT91383B (da)
RU (1) RU2074858C1 (da)
WO (1) WO1990001484A1 (da)
ZA (1) ZA895966B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
WO2008012830A1 (en) * 2006-07-28 2008-01-31 Hetero Drugs Limited Soup faropenem free acid
KR20160109904A (ko) * 2015-03-13 2016-09-21 주식회사 대웅제약 결정형 도리페넴의 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482565A (en) * 1980-02-22 1984-11-13 Farmitalia Carlo Erba S.P.A. β-Lactam-containing antibacterial agents and β-lactamase inhibitors
AT379399B (de) * 1981-12-11 1985-12-27 Erba Farmitalia Verfahren zur herstellung von optisch aktiven penemen
US4761408A (en) * 1984-11-02 1988-08-02 Ciba-Geigy Corporation Crystalline aminomethyl compound
US4634556A (en) * 1985-05-10 1987-01-06 Schering Corporation Crystalline sodium (5R, 6S, 8R)-6-(1-hydroxyethyl)-2-(2-carbamoyloxyethylthio)-penem-3-carboxylate and process for making same
FI871835L (fi) * 1986-04-29 1987-10-30 Ciba Geigy Ag Kristallint hydrat.
GB8915392D0 (en) * 1989-07-05 1989-08-23 Erba Carlo Spa Process for penems

Also Published As

Publication number Publication date
RU2074858C1 (ru) 1997-03-10
DE68918849T2 (de) 1995-02-23
KR900701799A (ko) 1990-12-04
CA1339422C (en) 1997-09-02
WO1990001484A1 (en) 1990-02-22
DK171235B1 (da) 1996-08-05
IE892528L (en) 1990-02-08
HU205934B (en) 1992-07-28
FI95575B (fi) 1995-11-15
JP2954956B2 (ja) 1999-09-27
EP0407478B1 (en) 1994-10-12
EP0407478A1 (en) 1991-01-16
GB8818789D0 (en) 1988-09-07
NZ230196A (en) 1990-09-26
IE68447B1 (en) 1996-06-26
FI901710A0 (fi) 1990-04-04
AU4049089A (en) 1990-03-05
PT91383B (pt) 1995-05-31
HU894594D0 (en) 1991-07-29
DE68918849D1 (de) 1994-11-17
ES2015770A6 (es) 1990-09-01
GR1002251B (en) 1996-04-23
US5302588A (en) 1994-04-12
IL91216A (en) 1994-10-21
FI95575C (fi) 1996-02-26
ATE112777T1 (de) 1994-10-15
PT91383A (pt) 1990-03-08
DK85490D0 (da) 1990-04-05
GR890100493A (el) 1990-08-22
ZA895966B (en) 1990-06-27
JPH03500781A (ja) 1991-02-21
IL91216A0 (en) 1990-03-19
HUT56571A (en) 1991-09-30
AU626576B2 (en) 1992-08-06

Similar Documents

Publication Publication Date Title
AR005009A1 (es) Monohidrato del cdch, procedimiento para su produccion , composiciones antibacteriales que lo contienen, uso del monohidrato del cdch para la manufactura de medicamentos.
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
CO4290432A1 (es) Nuevos derivados de pirazinacarboxamida, su preparacion y su utilizacion en medicamentos.
FI931332A0 (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
FI881644A7 (fi) Framstaellning av (1r,5s,6s)-2 -substituerade tio-6-/(r)-1-hydroxietyl/-1-metyl-karbapenem-2 -karboxylsyraderivat.
FR2664274B1 (fr) Procede de preparation de sulfates cycliques.
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK85490A (da) Krystallinsk (5r,6s)-2-carbamoyloxymethyl-6-((1r)-hydroxyethyl)-2-penemcarboxylsyre og dens farmaceutiske formulering
ATE66610T1 (de) Primycin enthaltendes kolloidales grundgel, verfahren zu dessen herstellung, dieses grundgel enthaltende pharmazeutische und pharmako- kosmetische kompositionen.
ES2020925B3 (es) Nuevas sales cristalinas de ariloxipropanolaminas, procedimiento para su preparacion y utilizacion de las mismas.
IT8948702A0 (it) Derivati gangliosidici, loro uso quali agenti terapeutici, procedimento per la loro produzione e composti farmaceutici che li contengono
FI906464A7 (fi) Menetelmä (1R,5S,6S)-2-((6,7-dihydro-5H-pyratsolo(1,2-a)(1,2,4)triatsolium-6-yl))tio-6-((R)-1-hydroksietyyli)-1-metyylikarbapeneemi-3-karboksylaatin valmistamiseksi ja menetelmässä käytetyt lähtöaineet
DK505485D0 (da) Krystallinsk (5r,6s)-2-aminomethyl-6-((1r)-1-hydroxyethyl)-2-penem-3-carboxylsyre samt dens fremstilling og anvendelse
FI883505A7 (fi) (1R,5S,6S)-2-substituoitu-tio-6 /(R)-1-hydroksietyyli/-1-metyyli-karbapenem-3 -karboksyylihappojohdannaisia.
FI872459A7 (fi) Farmaseuttinen valmiste bakteeri-infektioiden hoitoon.
DK174584D0 (da) Penemer,farmaceutiske praeparater indeholdende disse,samt fremgangsmaader til fremstilling deraf
AU578335B2 (en) N-substituted aziridine-2-carboxylic acid derivatives
PT89582A (pt) Processo para a preparacao de antibioticos beta-lactamicos uteis como medicamentos
NO165399C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive (5r,6s)-6-((r)-1-hydroksyetyl)-penem-derivater.
DE3464601D1 (en) 2-alkylthio-1-aminoalkyl-2-pyrroline-3-carbonitriles, process for their preparation and medicines with anti-thrombotic effects containing them
FI934054A0 (fi) Menetelmä antibakteeristen karboksyylihappojohdannaisten valmistuksessa käyttökelpoisten välituotteiden valmistamiseksi
DK0403325T3 (da) Diallyloxyeddikesyre og dennes basiske additionssalte, fremgangsmåde til dens fremstilling og anvendelse som tværbindingsmiddel
FI893096L (fi) Foerfarande foer givandet av deprenyl medicin pao ett saett som minimerar risken foer sidoeffekter.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed